MedTrace Logo

Familial Hypercholesterolemia in Turkey (A-HIT2)

NCT03110250 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-12-07

No results posted yet for this study

Summary

A-HIT2, is also designed as a National FH registry. At least 1000 FH patients will be recruited from 30 outpatient clinics representing the 12 Nuts statistical Regions in Turkey proportional to the 2015 Turkey's Population distribution.\[14\] Both HeFH and HoFH patients are eligible for enrollment. Sites specialized on cardiology, internal medicine, and endocrinology were invited by the Turkish Society of Cardiology.

Conditions

Sponsors & Collaborators

  • Turkish Society of Cardiology

    collaborator OTHER

  • Ege University

    lead OTHER

Principal Investigators

  • Meral Kayikcioglu · Ege University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-26
Primary Completion
2017-11-30
Completion
2017-12-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03110250 on ClinicalTrials.gov